Patents by Inventor André Rosenthal

André Rosenthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS FOR DIAGNOSING COLORECTAL CANCER
    Publication number: 20130065791
    Abstract: The invention pertains to a method for early detection and screening of colorectal cancer in human subjects based on RNA isolated from blood obtained from said subject. According to the invention, the abundance of at least 3, 5, 8, 30, 60, 102, 202, 55, 1002 or 1002 RNAs listed in tables 1 to 13 is measured. Using the invention, an accurate and noninvasive screening and diagnosis tool for colorectal cancer is provided with a sensitivity of at least 80% and a specificity of 85% that has high clinical utility and the potential for broad adoption.
    Type: Application
    Filed: May 19, 2011
    Publication date: March 14, 2013
    Applicant: SIGNATURE DIAGNOSTICS AG
    Inventors: André Rosenthal, Bernd Hinzmann, Tobias Mayr, Hans-Peter Adams
  • Human nucleic acid sequences from endometrial tumor tissue
    Patent number: 6620923
    Abstract: Human nucleic acid sequences—mRNA, cDNA, genomic sequences—from endometrial tumor tissue, which code for gene products or portions thereof, and their use, are described. In addition, the polypeptides that can be obtained by way of the sequences and their use are described.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: September 16, 2003
    Assignee: Metagen Pharmaceuticals GmbH
    Inventors: Thomas Specht, Bernd Hinzmann, Armin Schmitt, Christian Pilarsky, Edgar Dahl, André Rosenthal
  • Genomic sequence of Rhizobium sp. NGR 234 symbiotic plasmid
    Patent number: 6475793
    Abstract: The sequencing and analysis of the complete nucleotide sequence of symbiotic plasmid pNGR234a isolated from Rhizobium sp. NGR234. The complete sequence of pNGR234a is presented. The analysis includes the identification of a number of novel ORFs and the proteins expressible therefrom which have been ascribed putative functions.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: November 5, 2002
    Assignee: Andre Rosenthal
    Inventors: André Rosenthal, Christoph Bernward Freiberg, Xavier Philippe Perret, William John Broughton